Ronald Gieschke

Modeling and Simulation of Clinical Trials: An Industry Perspective

J. L. Steimer, Paul Jordan, Timothy Goggin, 2002 .

Interactive Visualization and Communication for Increased Impact of Pharmacometrics

Andreas Krause, Ronald Gieschke, R. Gieschke, 2010, Journal of clinical pharmacology.

A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis.

Timothy Goggin, Goonaseelan Pillai, Ronald Gieschke, 2004, British journal of clinical pharmacology.

An Integrated Glucose‐Insulin Model to Describe Oral Glucose Tolerance Test Data in Type 2 Diabetics

Ronald Gieschke, Mats O Karlsson, Nicolas Frey, 2007, Journal of clinical pharmacology.

Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid

Ronald Gieschke, E Niclas Jonsson, R. Gieschke, 2008, Journal of clinical pharmacology.

Integrated pharmacokinetics and pharmacodynamics of the novel catechol‐O‐methyltransferase inhibitor tolcapone during first administration to humans

Ronald Gieschke, Jasper Dingemanse, R. Gieschke, 1995, Clinical pharmacology and therapeutics.

An Integrated Model for Glucose and Insulin Regulation in Healthy Volunteers and Type 2 Diabetic Patients Following Intravenous Glucose Provocations

Ronald Gieschke, Mats O Karlsson, Nicolas Frey, 2007, Journal of clinical pharmacology.